All News

Article

ACR 2022 - Day 1 Report

Jack Cush, MD

The masses have returned to ACR22, a live, face-to-face, and virtual, meeting that began Saturday in Philadelphia. There were hassles and glitches, yet the education and sessions were as you’d expect with many good presentations worth recapping.

Aurelie Najm Tweet
AurelieRheumo
DANBIO registry: 1600+ pts RA, AxSpA, PsA Infiximab biosimilar to biosimilar switch (CT-P13 -> GP1111) Maintenance at 1yr: >80% > withdrawal in original IFX naive, but higher BL DA Do second time switchers do better because of past switch experience? Abs#1112 #ACR22 @RheumNow https://t.co/IgjhGLVESz
Robert B Chao, MD Tweet
doctorRBC
Biosimilar to biosimilar effective in treatment of RA/PsA/AxSpA. Large study looking at infliximab biosimilar switching - resulted in high retention rates and virtually no change in disease activity. @RheumNow #ACR22 Abs#1112 https://t.co/uNRXLewo4M
Robert B Chao, MD Tweet
doctorRBC
Most important point from the Great Debate on treating pre-RA. Are we really treating to prevent RA or are we simply delaying RA onset? I don't think there is enough data to treat pre-clinical RA with our current arsenal of DMARDs. What would you do? @RheumNow #ACR22
Robert B Chao, MD Tweet
doctorRBC
The Great Debate! Should you treat pre-clinical RA? ACPA+ ~40% did not convert to clinical RA RF+/ACPA+ least likely to seroconvert to negative @RheumNow #ACR22 https://t.co/djVPKDdWjz
Robert B Chao, MD Tweet
doctorRBC
The Great Debate! Should you treat pre-clinical RA? US erosions in 5th MTPs predict clinical arthritis in +CCP "Pre-RA" patients ~15% of patients will develop RA @RheumNow #ACR22 https://t.co/jS2YMlF4iO
Robert B Chao, MD Tweet
doctorRBC
The Great Debate! Should you treat pre-clinical RA? "The more good factors you have, the less likely you will develop RA" - Janet Pope Never smoker, normal BMI, low EtOH, exercise, healthy diet @RheumNow #ACR22 https://t.co/jIMOn8ht6u
Md Yuzaiful Md Yusof Tweet
Yuz6Yusof
#ACR22 The Great Debate: to treat subclinical #Rheumatoidarthritis or not. @Janetbirdope counted hands manually in person. Let's check out the #socialmedia community. What is your definition of sub-clinical RA? @RheumNow
Robert B Chao, MD Tweet
doctorRBC
Dr. Michael Holers on preclinical RA "Individuals who are anti-CCP positive are not clinically well. We just can't see what is going on" @RheumNow #ACR22
Robert B Chao, MD Tweet
doctorRBC
The Great Debate! Should you treat pre-clinical RA? First - likelihood of RA? If you have +ACPA or RF in sputum, there is 67% chance of developing clinical RA! @RheumNow #ACR22 https://t.co/K7pUhvbEDR
Aurelie Najm Tweet
AurelieRheumo
The great debate Next steps to develop RA prevention Kevin Deane “It’s time to move from disease modifying drugs to disease modifying therapeutic approaches” #ACRdebate #ACR22 @RheumNow https://t.co/3vt58sXlDx
David Liew Tweet
drdavidliew
USA vs Canada It's kicking off and a super hot topic The Great Debate: To Treat or Not? The Role of DMARDS in Subclinical Rheumatoid Arthritis Holers/Deane (treat 🇺🇸) El Gabalawy/Pope (don't treat 🇨🇦) What more do you want, #ACR22? Bring it on @RheumNow https://t.co/DroQdnSQHf
David Liew Tweet
drdavidliew
We know depression, anxiety are issues for many RA pts. Are we making the diagnosis more? Olmsted County data: depression similar over time anxiety 3x more common in 2005-2014 vs 1985-1994 (adj age/sex +/- others) How do we address this? ABST0886 @MayoClinic #ACR22 @RheumNow https://t.co/tzMEE24FZo
×